BioNTech SE (BNTX) Tops Q2 EPS by EUR1.86

BioNTech SE (NASDAQ: BNTX) reported Q2 EPS of EUR10.77, EUR1.86 better than the analyst estimate of EUR8.91. Revenue for the quarter came in at EUR5.31 billion versus the consensus estimate of EUR3.84 billion.

For earnings history and earnings-related data on BioNTech SE (BNTX) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• Bernstein SocGen Group Reiterates Outperform Rating on Robinhood Markets (HOOD)
• GE Aerospace to acquire Consolidated Precision in $11.75b deal